|
TOP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.618800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.642410E-02 |
| Normal-vs-Stage2 |
1.498130E-03 |
| Normal-vs-Stage3 |
1.002500E-03 |
| Normal-vs-Stage4 |
7.964500E-03 |
| Stage1-vs-Stage2 |
1.641580E-01 |
| Stage1-vs-Stage3 |
1.624640E-01 |
| Stage1-vs-Stage4 |
3.759800E-01 |
| Stage2-vs-Stage3 |
7.281200E-01 |
| Stage2-vs-Stage4 |
6.732800E-01 |
| Stage3-vs-Stage4 |
8.829400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.164400E-03 |
| Normal-vs-AfricanAmerican |
4.027800E-01 |
| Normal-vs-Asian |
1.207580E-02 |
| Caucasian-vs-AfricanAmerican |
3.730200E-01 |
| Caucasian-vs-Asian |
5.029200E-01 |
| AfricanAmerican-vs-Asian |
2.638200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.596600E-04 |
| Normal-vs-Female |
7.137300E-03 |
| Male-vs-Female |
1.652200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.347600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.624910E-03 |
| Normal-vs-Age(61-80Yrs) |
6.34800000000046E-05 |
| Normal-vs-Age(81-100Yrs) |
4.802400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.903390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.617910E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.966800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.484640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.306000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.761640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.098000E-01 |
| Classical-VS-Follicular |
1.04520003763042E-09 |
| Classical-VS-Other |
2.251600E-01 |
| Classical-VS-Normal |
9.370100E-02 |
| Tall-VS-Follicular |
1.860380E-03 |
| Tall-VS-Other |
3.544600E-01 |
| Tall-VS-Normal |
1.023440E-01 |
| Follicular-VS-Other |
4.775400E-01 |
| Follicular-VS-Normal |
6.60879995173502E-09 |
| Other-VS-Normal |
5.481600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.38689999999942E-05 |
| Normal-vs-N1 |
2.741600E-02 |
| N0-vs-N1 |
3.203400E-01 |
|
|
